R310 PRIA Fee Category

PRIA 3 Fee Determination Decision Tree:

Conventional New Product Registration - New End Use or Manufacturing Use

Below is the fee for your selected Fee Category for Fiscal Years 2016/2017

Action Code Description FY16/17 Fee Decision Time (months)
R310 New end-use or manufacturing-use product with registered source(s) of active ingredient(s); includes products containing two or more registered active ingredients previously combined in other registered products; requires review of data package within RD only; includes data and/or waivers of data for only: product chemistry and/or acute toxicity and/or public health pest efficacy and/or child resistant packaging. (2) (3) $ 5,301 7

Do you plan to request either of the following types of waivers?

Waiver Pay Amount
50% waiver You pay ---->>>>> $ 2,651
75% waiver You pay ---->>>>> $ 1,326

To pay the fee shown above, go to Paying PRIA Application Fees web page and follow the instructions.

How to submit your application directly to EPA.

Action Code Interpretation

An application for registration of an end-use or manufacturing use pesticide product that is not substantially similar or identical in its uses and formulation to products that are currently registered. To fit this category all applications require the following:

  • A data matrix is required with the application.
  • Product chemistry data (Group A and B) and CSF. In some cases product chemistry data can be satisfied as outlined in Pesticide Registration Notice 98-1.
  • All inert ingredients must already be approved or pending before the Agency for the applicable uses in the product.
  • Acute toxicity efficacy, public health pest efficacy, and/or child resistant packaging data requirements must be addressed by using: 1) the cite-all method, or 2) selective data citation which includes submitting required data. A rationale for a waiver or bridging of these data falls within this category.

An application proposed as a 100% re-packaged product does not fall within this category (see category R300). An end use animal product does not fit in this category (see R315).

If an applicant owns the generic data and therefore does not qualify for the formulator’s exemption, the new product application belongs in this category. The application does not fall into this category if it contains a request to waive generic data or a request to review any generic data.

Applications for new end use products that are submitted using an unregistered source of an existing active ingredient will be recoded to either category R333 or R334. All active ingredients derived from a manufacturing source which does not hold an active EPA registration number are considered unregistered. Even if the Agency may have reviewed the product chemistry data previously for that unregistered source of the active ingredient for another end use product, the active ingredient is considered unregistered.

The Agency will provide the applicant with a pre-decisional determination 2 weeks prior to the PRIA decision review time due date which specifies any label changes that have to be made in order to grant the requested new end-use product registration. If the label issues cannot be resolved prior to the PRIA decision review time due date and if a PRIA due date time extension has not been agreed upon, then the Agency will issue to the applicant its regulatory decision with the specific label changes and supporting documentation on or just before the PRIA decision review time due date. At that time the applicant must either (a) agree to all of the label changes and submit a revised label that incorporates all of these label changes; or (b) does not agree with one or more of the label changes and request up to 30 days to reach agreement with the Agency and submit a revised label that incorporates all of the agreed upon label changes, which the Agency has 2 business days to review; or (c) withdraw the application without prejudice.

Go to the start of the Decision Tree